Cantor Fitzgerald Weighs in on RARE FY2026 Earnings
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Ultragenyx Pharmaceutical in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska forecasts that the biopharmaceutical company will post earnings of ($2.61) per share for the year. Cantor Fitzgerald […]
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Ultragenyx Pharmaceutical in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska forecasts that the biopharmaceutical company will post earnings of ($2.61) per share for the year. Cantor Fitzgerald […]
